STEP 1 Content Outline
Respiratory System
Normal processes
- embryonic development, fetal maturation, and
perinatal changes
- organ structure and function
- airways, including mechanics
and regulation of breathing
- lung parenchyma, including
ventilation, perfusion, gas exchange
- pleura
- nasopharyx and sinuses
- cell/tissue structure and function, including surfactant
formation, alveolar structure
- repair, regeneration, and
changes associated with stage of life
- pulmonary defense
mechanisms and normal flora
Abnormal processes
- infectious, inflammatory, and immunologic
disorders
- infectious diseases
- infectious diseases of the
upper respiratory tract (eg, sinusitis, pharyngitis)
- acute
infectious diseases of the lower respiratory
tract and pleura and their complications (eg,
pneumonia, bronchiectasis, abscess,
empyema)
- chronic infectious diseases of the lower respiratory
tract (eg, Mycobacterium, endemic fungal infections,
Nocardia/Actinomyces)
- immunologic disorders
- allergic and hypersensitivity
disorders (eg, asthma)
- autoimmune disorders
(eg, Wegener granulomatosis, Goodpasture
syndrome)
- inflammatory disorders
- pneumoconioses
- acute and chronic alveolar
injury (eg, acute respiratory distress syndrome,
chlorine gas/smoke inhalation)
- obstructive pulmonary disease
- restrictive
pulmonary disease (eg, sarcoidosis, idiopathic
fibrosis)
- traumatic
and mechanical disorders (eg, foreign body aspiration, pneumothorax, atelectasis, sleep
apnea)
- neoplastic disorders (eg, polyps, bronchogenic
carcinoma, mesothelioma, metastatic tumors)
- metabolic,
regulatory, and structural disorders (eg, hypoventilation,
disorders of gas exchange, ventilation-perfusion imbalance, neonatal
respiratory distress syndrome)
- vascular and circulatory disorders (eg, thromboembolic
disease, pulmonary hypertension, pulmonary edema, pleural
effusion)
- systemic disorders affecting the respiratory
system
Principles of therapeutics
- mechanisms of action, use, and adverse effects
of drugs for treatment of disorders of the respiratory
system (eg, decongestants, cough suppressants,
expectorants, mucolytics; bronchodilator drugs; anti-inflammatory and cytotoxic
drugs; antimicrobial agents; antineoplastic agents)
- other therapeutic modalities
(eg, oxygen therapy, nasal CPAP, mechanical ventilation,
physical therapy, surgical procedures, including transplantation)
Gender, ethnic, and behavioral considerations affecting
disease treatment and prevention, including psychosocial,
cultural, occupational, and environmental
- emotional and behavioral factors (eg, smoking,
substance abuse, pets, and allergies)
- influence on person,
family, and society (eg, tuberculosis, asthma, chronic
obstructive pulmonary disease, school issues, protective
parents,
family smoking)
- occupational and other environmental risk factors
- gender
and ethnic factors (eg, sarcoidosis, lung cancer)